Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,468 | 84,887 | 190,714 | 89,323 | 108,396 |
| Marketable Securities | 195,710 | 278,167 | 213,769 | 183,463 | 119,642 |
| Receivables | 60,119 | 43,411 | 37,154 | 25,807 | 19,417 |
| Inventories | 14,015 | 13,880 | 13,247 | 13,134 | 13,913 |
| TOTAL | $423,720 | $434,591 | $468,062 | $330,431 | $281,548 |
| Non-Current Assets | |||||
| PPE Net | 1,186 | 1,347 | 1,369 | 1,539 | 1,735 |
| Intangibles | 9,792 | 6,063 | 6,250 | 6,438 | 6,625 |
| Other Non-Current Assets | 2,656 | 2,758 | 2,860 | 2,957 | 3,051 |
| TOTAL | $13,634 | $10,168 | $10,479 | $10,934 | $11,411 |
| Total Assets | $437,354 | $444,759 | $478,541 | $341,365 | $292,959 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 99,513 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 19,325 | 7,943 | 12,969 | 11,992 | 13,179 |
| Accrued Expenses | 52,790 | 42,632 | 33,584 | 33,941 | 27,995 |
| TOTAL | $172,426 | $51,352 | $47,309 | $46,668 | $41,889 |
| Non-Current Liabilities | |||||
| Long Term Debt | 105,095 | 203,808 | 202,803 | 201,799 | 200,783 |
| Other Non-Current Liabilities | 3,192 | 3,172 | 3,487 | 4,231 | 3,570 |
| TOTAL | $108,287 | $206,980 | $206,290 | $206,030 | $204,353 |
| Total Liabilities | $280,713 | $258,332 | $253,599 | $252,698 | $246,242 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,045 | 116,891 | 115,764 | 96,813 | 94,382 |
| Common Shares | 12 | 12 | 12 | 9 | 6 |
| Retained earnings | -1,111,155 | -1,069,618 | -1,017,286 | -981,904 | -915,620 |
| Other shareholders' equity | 533 | -294 | -133 | 4 | -184 |
| TOTAL | $156,641 | $186,427 | $224,942 | $88,667 | $46,717 |
| Total Liabilities And Equity | $437,354 | $444,759 | $478,541 | $341,365 | $292,959 |